Logo.jpg
RYVYL Inc. Announces Launch of Proposed Underwritten Public Offering
April 15, 2024 16:27 ET | RYVYL Inc.
San Diego, CA, April 15, 2024 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL) ("RYVYL" or the "Company"), a leading innovator of payment transaction solutions leveraging proprietary blockchain ledger...
Nouveau Logo communiqué de presse.JPG
Theratechnologies annonce l’envoi de sa circulaire de sollicitation de procurations en vue de l’assemblée annuelle des actionnaires
April 15, 2024 16:15 ET | Theratechnologies
MONTRÉAL, 15 avr. 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une entreprise biopharmaceutique axée sur la mise au...
Nouveau Logo communiqué de presse.JPG
Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders
April 15, 2024 16:15 ET | Theratechnologies
MONTREAL, April 15, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...
Ben Logo.png
Beneficient to Participate in the Planet MicroCap Showcase on May 1-2, 2024
April 15, 2024 16:15 ET | Beneficient
Beneficient (Nasdaq: BENF) will present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 at 2:00 p.m. Pacific Daylight Time.
ORIC Logo_RGB.png
ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC
April 15, 2024 16:15 ET | ORIC Pharmaceuticals
Initiated multiple Phase 1b expansion cohorts to determine the RP2D of ORIC-114 in NSCLC patients with EGFR exon 20, HER2 exon 20, or EGFR atypical mutations Additionally, the company initiated an...
OTLK.png
Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million
April 15, 2024 16:15 ET | Outlook Therapeutics, Inc.
ISELIN, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of...
image1
Tidewater Utilities Announces Strategy for Compliance With New EPA PFAS Regulation
April 15, 2024 16:10 ET | Middlesex Water Company
Tidewater Announces Strategy to Comply with new EPA
Chardan Logo.png
Dragonfly Energy Reports Fourth Quarter 2023 and Full Year Financial Results
April 15, 2024 16:10 ET | Dragonfly Energy Holdings Corp.
Dragonfly Energy, an industry leader in energy storage, today reported financial and operational results for 4Q and year ended December 31, 2023.
SIBN_logo.jpg
SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024
April 15, 2024 16:09 ET | SI-BONE, Inc.
SANTA CLARA, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy today...
CNBFC logomark (RGB).jpg
CNB Financial Corporation Reports First Quarter 2024 Results
April 15, 2024 16:05 ET | CNB Financial
CLEARFIELD, Pa., April 15, 2024 (GLOBE NEWSWIRE) -- CNB Financial Corporation (“Corporation”) (NASDAQ: CCNE), the parent company of CNB Bank, today announced its earnings for the three months ended...